329 related articles for article (PubMed ID: 16698258)
1. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
Wauer RR; Schmalisch G; Rogalski M
Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
[TBL] [Abstract][Full Text] [Related]
4. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
[TBL] [Abstract][Full Text] [Related]
5. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
[TBL] [Abstract][Full Text] [Related]
6. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
7. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
Bevilacqua G; Parmigiani S;
J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
[TBL] [Abstract][Full Text] [Related]
8. [The use of Curosurf with premature infants--the prevention or treatment of the neonatal RDS].
Iarŭkova N; Chernev T; Nikolov A
Akush Ginekol (Sofiia); 1998; 37(3):12-4. PubMed ID: 10204257
[TBL] [Abstract][Full Text] [Related]
9. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
[TBL] [Abstract][Full Text] [Related]
10. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
11. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
Parmigiani S; Panza C; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
[TBL] [Abstract][Full Text] [Related]
12. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial.
Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717
[TBL] [Abstract][Full Text] [Related]
13. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
Network of Northwest Neonatal Professional Collaboration Group
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
16. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
[TBL] [Abstract][Full Text] [Related]
17. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
19. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome.
Cogo PE; Facco M; Simonato M; Verlato G; Rondina C; Baritussio A; Toffolo GM; Carnielli VP
Pediatrics; 2009 Nov; 124(5):e950-7. PubMed ID: 19822594
[TBL] [Abstract][Full Text] [Related]
20. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
